These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17962328)

  • 21. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
    Bettini E; Sava A; Griffante C; Carignani C; Buson A; Capelli AM; Negri M; Andreetta F; Senar-Sancho SA; Guiral L; Cardullo F
    J Pharmacol Exp Ther; 2010 Dec; 335(3):636-44. PubMed ID: 20810618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology.
    Monaghan DT; Larsen H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):614-20. PubMed ID: 9023271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The selectivity of conantokin-G for ion channel inhibition of NR2B subunit-containing NMDA receptors is regulated by amino acid residues in the S2 region of NR2B.
    Sheng Z; Liang Z; Geiger JH; Prorok M; Castellino FJ
    Neuropharmacology; 2009 Aug; 57(2):127-36. PubMed ID: 19427876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subunit-specific effects of poricoic acid A on NMDA receptors.
    Lee J; Kim C; Yeom HD; Nguyen KVA; Eom S; Lee S; Jung JH; Lee JH; Kim SH; Kim IK; Lee JH
    Pharmacol Rep; 2020 Apr; 72(2):472-480. PubMed ID: 32048268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjacent asparagines in the NR2-subunit of the NMDA receptor channel control the voltage-dependent block by extracellular Mg2+.
    Wollmuth LP; Kuner T; Sakmann B
    J Physiol; 1998 Jan; 506 ( Pt 1)(Pt 1):13-32. PubMed ID: 9481670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits.
    Smothers CT; Woodward JJ
    J Pharmacol Exp Ther; 2007 Aug; 322(2):739-48. PubMed ID: 17502428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
    Frizelle PA; Chen PE; Wyllie DJ
    Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NR2B and NR2D subunits coassemble in cerebellar Golgi cells to form a distinct NMDA receptor subtype restricted to extrasynaptic sites.
    Brickley SG; Misra C; Mok MH; Mishina M; Cull-Candy SG
    J Neurosci; 2003 Jun; 23(12):4958-66. PubMed ID: 12832518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential modulation of NR1-NR2A and NR1-NR2B subtypes of NMDA receptor by PDZ domain-containing proteins.
    Iwamoto T; Yamada Y; Hori K; Watanabe Y; Sobue K; Inui M
    J Neurochem; 2004 Apr; 89(1):100-8. PubMed ID: 15030393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spermine potentiation of recombinant N-methyl-D-aspartate receptors is affected by subunit composition.
    Zhang L; Zheng X; Paupard MC; Wang AP; Santchi L; Friedman LK; Zukin RS; Bennett MV
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10883-7. PubMed ID: 7971977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The N-terminal domains of both NR1 and NR2 subunits determine allosteric Zn2+ inhibition and glycine affinity of N-methyl-D-aspartate receptors.
    Madry C; Mesic I; Betz H; Laube B
    Mol Pharmacol; 2007 Dec; 72(6):1535-44. PubMed ID: 17878266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethanol sensitivity of heteromeric NMDA receptors: effects of subunit assembly, glycine and NMDAR1 Mg(2+)-insensitive mutants.
    Mirshahi T; Woodward JJ
    Neuropharmacology; 1995 Mar; 34(3):347-55. PubMed ID: 7630488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential contribution of the NR1- and NR2A-subunits to the selectivity filter of recombinant NMDA receptor channels.
    Wollmuth LP; Kuner T; Seeburg PH; Sakmann B
    J Physiol; 1996 Mar; 491 ( Pt 3)(Pt 3):779-97. PubMed ID: 8815211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residues at the tip of the pore loop of NR3B-containing NMDA receptors determine Ca2+ permeability and Mg2+ block.
    Cavara NA; Orth A; Hicking G; Seebohm G; Hollmann M
    BMC Neurosci; 2010 Oct; 11():133. PubMed ID: 20958962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of NMDA receptor function by the NR2 subunit amino-terminal domain.
    Yuan H; Hansen KB; Vance KM; Ogden KK; Traynelis SF
    J Neurosci; 2009 Sep; 29(39):12045-58. PubMed ID: 19793963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of glycine antagonist sites of N-methyl-D-aspartate receptor subtypes. Preferential interaction of CGP 61594 with NR1/2B receptors.
    Honer M; Benke D; Laube B; Kuhse J; Heckendorn R; Allgeier H; Angst C; Monyer H; Seeburg PH; Betz H; Mohler H
    J Biol Chem; 1998 May; 273(18):11158-63. PubMed ID: 9556603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of NR1/NR2 and NR1/NR3 heterodimers constitutes the initial step in N-methyl-D-aspartate receptor assembly.
    Schüler T; Mesic I; Madry C; Bartholomäus I; Laube B
    J Biol Chem; 2008 Jan; 283(1):37-46. PubMed ID: 17959602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits.
    Williams K; Zappia AM; Pritchett DB; Shen YM; Molinoff PB
    Mol Pharmacol; 1994 May; 45(5):803-9. PubMed ID: 8190097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A regulatory domain (R1-R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein.
    Masuko T; Kashiwagi K; Kuno T; Nguyen ND; Pahk AJ; Fukuchi J; Igarashi K; Williams K
    Mol Pharmacol; 1999 Jun; 55(6):957-69. PubMed ID: 10347236
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.